UBRELVY 50 mg/1 (Ubrogepant TABLET) 50 mg/1

UBRELVY 50 mg tablets contain ubrogepant, a medication used for the acute treatment of migraines. This oral medication is designed to provide relief from migraine pain and associated symptoms. Ubrogepant is a selective calcitonin gene-related peptide (CGRP) receptor antagonist.

Strength

50 mg/1

Pack Size

4 PACKET in 1 BOX (0023-6498-04) / 1 TABLET in 1 PACKET

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

UBRELVY 50 mg tablets are primarily used for the acute treatment of migraines with or without aura in adults. This medication is intended to alleviate the pain and other symptoms associated with migraines. Ubrogepant works by blocking the activity of CGRP, a protein involved in migraine attacks. It is important to consult a healthcare provider to determine if this medication is suitable for your specific condition.

Side Effects

Common effects of Ubrevly 50 mg tablets may include nausea, somnolence, and dry mouth. Some users may experience fatigue or dizziness. These effects are generally mild and temporary. If you experience severe or persistent side effects, it is advisable to seek medical attention.

Precautions & Warnings

UBRELVY 50 mg tablets should be used with caution in individuals with a history of liver problems or those taking certain medications that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.

Avoid Interactions

UBRELVY 50 mg tablets may interact with other medications, including those metabolized by the liver enzyme CYP3A4. It is important to avoid alcohol while taking this medication, as it may increase the risk of side effects. Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to ensure safe and effective use.

Frequently Asked Questions

UBRELVY 50 mg tablets are used for the acute treatment of migraines with or without aura in adults.

UBRELVY 50 mg tablets are taken orally with water. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, somnolence, dry mouth, fatigue, and dizziness.

UBRELVY may interact with other medications, especially those metabolized by the liver enzyme CYP3A4. Consult your healthcare provider before combining medications.

Pregnant or breastfeeding women should consult their healthcare provider before using Ubrevly to ensure safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.